Internal Medicine Alert – June 30, 2020
June 30, 2020
View Issues
-
Making Healthy Lifestyle Choices, Living Longer Without Chronic Diseases
The authors found improving each of four “healthy lifestyle choices” added approximately one year of disease-free life between ages 40 and 75 years. Adopting all four “optimal” lifestyles was associated with nine years of life gained vs. adopting zero optimal lifestyles.
-
Benefits of Targeting LDL Cholesterol Below 70 mg/dL
After an ischemic stroke of atherosclerotic origin, targeting low-density lipoprotein cholesterol to less than 70 mg/dL resulted in a significant reduction in subsequent major vascular events and no increase in intracranial hemorrhage.
-
Disability After Minor Stroke and TIA — Secondary Analysis of the POINT Trial
Although the data from this analysis suggest disability might be less with dual antiplatelet therapy, differences between the groups were small, did not show robust findings, and did not reach statistical significance in most of the analyses.
-
Type of Provider and Opioid Use in New-Onset Low Back Pain
When compared to an initial visit with a primary care physician, patients who initially received care for new-onset low back pain from a chiropractor, physical therapist, or acupuncturist were at lower odds for early and long-term opioid use.
-
How Does Weight Loss Affect Lower Urinary Symptoms and Incontinence in Obese and Overweight Women?
Weight loss interventions were associated with improvements in urinary incontinence in overweight and obese women at one to 2.9 years.
-
Selpercatinib Capsules (Retevmo)
Selpercatinib should be prescribed to treat metastatic rearranged during transfection (RET) fusion-positive, non-small cell lung cancer and advanced or metastatic RET-mutant medullary thyroid cancer.